Overview
In today’s digital-first world, patients often begin their healthcare journey online—searching for symptoms, reading about conditions, and looking for credible treatment options. For pharma companies, this shift presents both a challenge and an opportunity: how to educate patients effectively, guide them toward trusted resources, and ultimately connect them to the right healthcare professionals (HCPs).
A global pharmaceutical leader in a niche therapy area faced exactly this challenge. While the company had launched a breakthrough treatment, awareness among patients remained low, and there was no centralized platform for education and engagement. To bridge this critical gap, the company partnered with Zelthy to build a disease awareness and patient engagement platform that combined education, action, and measurable outcomes.
Challenges
While the pharma company had launched an innovative treatment in a niche therapy area, it faced several challenges in reaching and educating potential patients:
- Low patient awareness: Limited understanding of the disease and therapy options.
- Lack of centralized resources: No reliable digital hub for patient-friendly education.
- Fragmented patient journeys: Drop-offs between online research and offline consultation.
- Limited visibility on impact: Difficulty measuring awareness-to-action conversions.
- HCP engagement gaps: Doctors lacked structured support and qualified patient referrals.
To succeed, the company needed a digital-first solution that could connect awareness with action—informing patients, encouraging consultations, and strengthening relationships with HCPs.
Solution
Using Zelthy, the pharma company launched a comprehensive digital therapy awareness platform, accessible via web and mobile.
Key features included:
- Patient-Friendly Website: Clear, accessible content to educate patients on the condition and available treatment.
- Targeted Campaigns: Social media and Google ads drove traffic to the platform, meeting patients where they already were.
- Seamless Consultation Booking: Patients could directly schedule consultations with specialists or partner clinics via integrated CTAs.
- CRM Integration: End-to-end patient journey tracking ensured visibility from awareness through to therapy initiation.
- Real-Time Analytics: Dashboards highlighted traffic, conversions, and drop-off points, enabling data-driven optimization.
- HCP Support: Doctors received warm, qualified patient leads along with educational resources to enhance credibility and patient trust.
Impact
The initiative drove value across the board—improving patient access while building long-term HCP loyalty:
- 500,000+ website visits in the first 9 months.
- 80,000+ consultation requests submitted by patients.
- 30% conversion rate from visitor to booked appointment.
- 2x increase in therapy initiations in targeted geographies.
- Enhanced HCP loyalty and equity by driving warm patient leads to partner clinics and supporting physicians with disease awareness materials
- Better engagement insights into patient behavior, interests, and informational gaps
Why Zelthy
The company selected Zelthy for its:
- Rapid deployment capabilities in regulated healthcare environments.
- End-to-end patient journey orchestration, from awareness to therapy initiation.
- Built-in tools for measuring both patient outcomes and HCP impact
- Proven success in delivering digital-first pharma transformation initiatives
Conclusion
By partnering with Zelthy, the pharma company was able to transform its patient engagement strategy from fragmented campaigns into a holistic digital health initiative. Patients gained access to trusted resources and timely care, HCPs benefited from qualified referrals, and the company achieved measurable growth in therapy initiations.
This case study highlights how pharma leaders can leverage Zelthy’s scalable, compliant platform to move beyond awareness, creating patient-centric ecosystems that drive real healthcare outcomes.
